| GSE86982 | GSM2317309 | Illumina HiSeq 2500 | Homo sapiens | 26Dp4_H02_smart-seq | cultured embryonic stem cells[DCX+][BG121099] | days in culture: 26; cre line: DCX+; differentiation#: BG121099; control: FALSE |
| GSE86982 | GSM2317565 | Illumina HiSeq 2500 | Homo sapiens | 54Dn4_G10_smart-seq | cultured embryonic stem cells[DCX-][BG121099] | days in culture: 54; cre line: DCX-; differentiation#: BG121099; control: FALSE |
| GSE86982 | GSM2317821 | Illumina HiSeq 2500 | Homo sapiens | 26Dp3_G10_smart-seq | cultured embryonic stem cells[DCX+][RM165049] | days in culture: 26; cre line: DCX+; differentiation#: RM165049; control: FALSE |
| GSE86982 | GSM2318077 | Illumina HiSeq 2500 | Homo sapiens | 54Dn5_G08_smart-seq | cultured embryonic stem cells[DCX-][RM165048] | days in culture: 54; cre line: DCX-; differentiation#: RM165048; control: FALSE |
| GSE86982 | GSM2318333 | Illumina HiSeq 2500 | Homo sapiens | SK_3_E05_smart-seq | cultured embryonic stem cells[RM165095][viral_barcoded] | days in culture: 54; differentiation#: RM165095; control: FALSE; viral barcoded: viral_barcoded |
| GSE52529 | GSM1269136 | Illumina HiSeq 2500 | Homo sapiens | Cell T24_CT_G09 | Human Skeletal Muscle Myoblasts (HSMM) | cell type: Human Skeletal Muscle Myoblasts (HSMM); hour post serum-switch: 24; debris: FALSE; control well: FALSE; cells in well: 0; library protocol: Single-cell |
| GSE53386 | GSM1290637 | Illumina HiSeq 2500 | Homo sapiens | SUPeR-seq__HEK293T6 | HEK293T | cell line: HEK293T |
| GSE57872 | GSM1395521 | Illumina HiSeq 2500 | Homo sapiens | Single cell mRNA-seq_MGH26-2_C03 | glioblastoma [Pro] | patient id: MGH26; cell type: Glioblastoma; subtype: Pro |
| GSE57872 | GSM1395777 | Illumina HiSeq 2500 | Homo sapiens | Single cell mRNA-seq_MGH29_H07 | glioblastoma [Neu] | patient id: MGH29; cell type: Glioblastoma; subtype: Neu |
| GSE64016 | GSM1562617 | Illumina HiSeq 2500 | Homo sapiens | G1_Exp1.018 | single H1-Fucci cell sorted from G1 phase of the cell cycle only | cell type: human embryonic stem cells; passages: 35-40; treatment: FACS sorted |
